JPM European Media Internet 2019 Outlook_watermark
.pdfvk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Informa: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
1,379 |
1,758 |
2,393 |
2,875 |
2,969 |
|
Cash flow from operating activities |
336 |
434 |
451 |
722 |
809 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
234 |
230 |
193 |
194 |
197 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
21 |
(9) |
(144) |
(36) |
15 |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
440 |
585 |
744 |
946 |
984 |
|
Cash flow from investing activities |
(1,403) |
(284) |
(4,673) |
(86) |
(81) |
D&A |
(234) |
(230) |
(193) |
(194) |
(197) |
|
o/w Capital expenditure |
(52) |
(79) |
(87) |
(89) |
(90) |
Adj. EBIT |
205 |
355 |
551 |
751 |
787 |
|
as % of sales |
3.8% |
4.5% |
3.6% |
3.1% |
3.0% |
Net Interest |
(40) |
(59) |
(87) |
(100) |
(85) |
|
|
|
|
|
|
|
Adj. PBT |
383 |
486 |
625 |
814 |
871 |
|
Cash flow from financing activities |
1,056 |
(140) |
4,026 |
(266) |
(277) |
Tax |
(68) |
(103) |
(116) |
(155) |
(174) |
|
o/w Dividends paid |
(135) |
(164) |
(217) |
(266) |
(277) |
Minority Interest |
2 |
2 |
6 |
3 |
3 |
|
o/w Shares issued/(repurchased) |
760 |
0 |
3,545 |
0 |
0 |
Adj. Net Income |
313 |
381 |
503 |
656 |
693 |
|
o/w Net debt issued/(repaid) |
431 |
184 |
703 |
0 |
0 |
Reported EPS |
43 51 |
46.69 |
48.60 |
52.88 |
55.82 |
|
Net change in cash |
(10) |
10 |
(196) |
370 |
451 |
Adj. EPS |
42.99 |
46.11 |
47.46 |
52.40 |
55.34 |
|
|
317 |
402 |
435 |
715 |
787 |
DPS |
19.30 |
20.45 |
21.27 |
22.12 |
23.00 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
(2.5%) |
26.6% |
8.2% |
64.4% |
10.1% |
||||||
Payout ratio |
44.4% |
43.8% |
43.8% |
41.8% |
41.2% |
|
|
|
|
|
|
|
Shares outstanding |
728 |
826 |
1,060 |
1,252 |
1,253 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
50 |
55 |
4 |
375 |
825 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
356 |
401 |
811 |
963 |
983 |
|
EBITDA margin |
31.9% |
33.3% |
31.1% |
32.9% |
33.1% |
Inventories |
52 |
54 |
81 |
95 |
95 |
|
EBIT margin |
14.9% |
20.2% |
23.0% |
26.1% |
26.5% |
Other current assets |
31 |
25 |
34 |
34 |
34 |
|
Net profit margin |
22.7% |
21.7% |
21.0% |
22.8% |
23.4% |
Current assets |
489 |
536 |
930 |
1,466 |
1,936 |
|
Organic Revenue growth |
1.6% |
3.4% |
4.2% |
3.0% |
3.3% |
PP&E |
24 |
32 |
87 |
101 |
114 |
|
Net debt/EBITDA |
3.4 |
2.3 |
2 9 |
1 9 |
1.3 |
LT investments |
17 |
16 |
197 |
273 |
367 |
|
|
|
|
|
|
|
Other non current assets |
4,502 |
4,310 |
9,984 |
9,814 |
9,642 |
|
Sales/Assets (x) |
0 3 |
0.4 |
0 3 |
0 3 |
0.3 |
Total assets |
5,032 |
4,893 |
11,198 |
11,654 |
12,059 |
|
Assets/Equity (x) |
2 3 |
2.3 |
1 9 |
1.7 |
1.7 |
|
|
|
|
|
|
|
Interest cover (x) |
10 9 |
9.9 |
8 5 |
9 5 |
11.5 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
175 |
303 |
303 |
303 |
303 |
|
Tax rate |
17.8% |
21.2% |
18.5% |
19.0% |
20.0% |
Payables |
247 |
297 |
585 |
709 |
738 |
|
|
|
|
|
|
|
Other short term liabilities |
627 |
590 |
1,077 |
1,077 |
1,077 |
|
Revenue y/y Growth |
13.7% |
27.5% |
36.1% |
20.2% |
3.3% |
Current liabilities |
1,049 |
1,190 |
1,965 |
2,088 |
2,118 |
|
EBITDA y/y Growth |
13.5% |
33.1% |
27.2% |
27.1% |
4.1% |
Long-term debt |
1,360 |
1,125 |
1,828 |
1,828 |
1,828 |
|
EPS y/y Growth |
8.9% |
7 3% |
2.9% |
10.4% |
5.6% |
Other long term liabilities |
435 |
346 |
968 |
968 |
968 |
|
|
|
|
|
|
|
Total liabilities |
2,844 |
2,661 |
4,761 |
4,885 |
4,914 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
2,187 |
2,219 |
6,464 |
6,800 |
7,179 |
|
P/E (x) |
15 2 |
14.1 |
13.7 |
12.4 |
11.8 |
Minority interests |
1 |
11 |
(28) |
(31) |
(34) |
|
FCFE Yield |
- |
- |
- |
- |
- |
Total liabilities & equity |
5,032 |
4,892 |
11,198 |
11,654 |
12,059 |
|
EV/EBITDA (x) |
14.7 |
11.9 |
12 5 |
10.8 |
10.0 |
|
|
|
|
|
|
|
Dividend Yield |
3.0% |
3.1% |
3.3% |
3.4% |
3.5% |
Net debt/(cash) |
1,486 |
1,373 |
2,127 |
1,757 |
1,306 |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: £ in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
51
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Overweight
Company Data
Price (p) |
131 |
Date Of Price |
07 Dec 18 |
Price Target (p) |
175 |
Price Target End Date |
30-Sep-19 |
52-week Range (p) |
183-131 |
Market Cap (£ bn) |
5.26 |
Shares O/S (mn) |
4,006 |
ITV: DCF (£m)
Wacc |
9.4% |
Terminal growth |
1.3% |
NPV 2018-30 |
4,423 |
Terminal value |
2,855 |
EV |
7,278 |
Less Net Debt |
-958 |
Less earnouts |
-260 |
Pension Deficit |
0 |
Britbox – US / UK |
37 |
Equity |
6,097 |
No Shares |
4,006 |
Equity value / share |
152 |
M&A premium |
15% |
Equity value / share |
175 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
ITV
ITV (ITV.L;ITV LN)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (p) |
16.03 |
15.34 |
14.23 |
14.04 |
Revenue FY (£ mn) |
3,132 |
3,243 |
3,347 |
3,346 |
Adjusted EBITA FY (£ mn) |
847 |
811 |
753 |
743 |
EBITA Margin FY |
27.0% |
25.0% |
22.5% |
22.2% |
EBIT FY (£ mn) |
842 |
807 |
750 |
740 |
Net Profit FY (£ mn) |
642 |
615 |
570 |
562 |
Bloomberg EPS FY (p) |
15.70 |
15.00 |
- |
14.40 |
DPS (Net) FY (p) |
7.80 |
8.00 |
8.00 |
8.00 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks ITV (Overweight; Price Target: 175p)
Forecast changes
We have marginally reduced our 2019 / 20 NAR estimates from -1.7% / -0.5% to -2.4% / -1.5% to reflect a slightly more conservative view on UK TV advertising outlook. As a result our 2019 / 20 EPS decrease by -1.5% / -3.5%.
Investment Thesis
ITV trades on c8.5x 2019E EPS and offers a 8% yield. While our economists believe a negotiated Brexit deal, which could drive a strong recovery in UK advertising, is the most likely scenario, uncertainty is likely to continue to weigh on the share price and advertising until a deal is negotiated and approved by the UK parliament.
We believe an extended video day, inelastic demand for TV advertising and structural growth in ITV's audience share as traditional pay TV penetration declines, will offset the gradual decline in linear audiences. Technology transforms the FTA TV user experience and technology / a shift in consumption opens up new revenue streams from: 1) data driven, targeted advertising for both on demand and, more importantly, linear audiences; 2) B2B distribution revenues; 3) Direct to Consumer / subscriptions; and 4) increased global demand for content. We see opportunities for broadcasters to co-operate / consolidate to benefit from increased scale, to create a compelling offering for consumers, cut costs & share the investment required to unlock new revenues streams. We also see scope for strategic upside: from vertical integration as telco’s seek to differentiate and better monetize their distribution; from US media companies seeking diversification, European distribution and scale in content; & tech giants seeking engagement and access to broadcasters’ huge volume / share of video ad inventory which will become addressable in the coming years.
Valuation
Our DCF based PT decreases from 215p to 175p as a result of our reduced estimates - this assumes a WACC of 9.4% (vs. 8.5% before), terminal growth of 1.3% and includes a 15% strategic premium.
Risks to Rating and Price Target
The following risks could prevent the stock from achieving our target price and rating: 1) UK TV advertising market weaker than our forecasts; 2) Weaker-than- expected audience share; 3) weaker programme and format sales for ITV Studios.
52
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
ITV: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
3,064 |
3,132 |
3,243 |
3,346 |
3,442 |
|
Cash flow from operating activities |
661 |
444 |
500 |
562 |
592 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
43 |
35 |
44 |
48 |
52 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
(28) |
(58) |
(15) |
(15) |
(15) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
928 |
877 |
851 |
789 |
818 |
|
Cash flow from investing activities |
(174) |
(129) |
(170) |
(130) |
(131) |
D&A |
(43) |
(35) |
(44) |
(48) |
(52) |
|
o/w Capital expenditure |
(44) |
(71) |
(100) |
(60) |
(61) |
Adj. EBIT |
885 |
842 |
807 |
740 |
766 |
|
as % of sales |
1.4% |
2.3% |
3.1% |
1.8% |
1.8% |
Net Interest |
(26) |
(33) |
(34) |
(33) |
(34) |
|
|
|
|
|
|
|
Adj. PBT |
553 |
500 |
573 |
579 |
606 |
|
Cash flow from financing activities |
(206) |
(762) |
(336) |
(363) |
(427) |
Tax |
(160) |
(154) |
(146) |
(134) |
(139) |
|
o/w Dividends paid |
(667) |
(498) |
(334) |
(463) |
(427) |
Minority Interest |
(4) |
(4) |
(4) |
(4) |
(4) |
|
o/w Shares issued/(repurchased) |
(20) |
(36) |
0 |
0 |
0 |
Adj. Net Income |
683 |
642 |
615 |
562 |
578 |
|
o/w Net debt issued/(repaid) |
481 |
(228) |
0 |
0 |
0 |
Reported EPS |
17.03 |
16.03 |
15.34 |
14.04 |
14.43 |
|
Net change in cash |
281 |
(447) |
(5) |
69 |
34 |
Adj. EPS |
17.03 |
16.03 |
15.34 |
14.04 |
14.43 |
|
|
661 |
444 |
418 |
487 |
527 |
DPS |
7.20 |
7.80 |
8.00 |
8.00 |
8.00 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
39.5% |
(32.8%) |
(5.7%) |
16.4% |
8.2% |
||||||
Payout ratio |
42.3% |
48.7% |
52.1% |
57.0% |
55.4% |
|
|
|
|
|
|
|
Shares outstanding |
4,010 |
4,006 |
4,006 |
4,006 |
4,006 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
561 |
126 |
100 |
114 |
106 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
990 |
1,136 |
1,051 |
1,006 |
960 |
|
EBITDA margin |
30.3% |
28.0% |
26.2% |
23.6% |
23.8% |
Inventories |
- |
- |
- |
- |
- |
|
EBIT margin |
28.9% |
26 9% |
24.9% |
22.1% |
22.3% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
22.3% |
20 5% |
19.0% |
16.8% |
16.8% |
Current assets |
1,551 |
1,262 |
1,151 |
1,120 |
1,066 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
2,032 |
2,089 |
2,028 |
1,993 |
1,957 |
|
Net debt/EBITDA |
68.9% |
106 3% |
112.6% |
119.6% |
116.4% |
LT investments |
|
|
|
- |
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0 9 |
0.9 |
1.0 |
1.1 |
1.1 |
Total assets |
3,583 |
3,351 |
3,179 |
3,113 |
3,023 |
|
Assets/Equity (x) |
3 5 |
4.7 |
4.7 |
4.8 |
4.8 |
|
|
|
|
|
|
|
Interest cover (x) |
35.7 |
26.6 |
25.1 |
23.6 |
24.4 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
|
|
|
- |
- |
|
Tax rate |
28.9% |
30.8% |
25.5% |
23.1% |
22.9% |
Payables |
1,628 |
1,563 |
1,463 |
1,403 |
1,342 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
3.1% |
2.2% |
3.5% |
3.2% |
2.9% |
Current liabilities |
1,628 |
1,563 |
1,463 |
1,403 |
1,342 |
|
EBITDA y/y Growth |
1.9% |
(5 5%) |
(3.0%) |
(7.3%) |
3.8% |
Long-term debt |
1,200 |
1,058 |
1,058 |
1,058 |
1,058 |
|
EPS y/y Growth |
3.5% |
(5 9%) |
(4.3%) |
(8.5%) |
2.8% |
Other long term liabilities |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
Total liabilities |
2,828 |
2,621 |
2,521 |
2,461 |
2,400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
755 |
730 |
658 |
652 |
623 |
|
P/E (x) |
7.7 |
8.2 |
8.6 |
9.4 |
9.1 |
Minority interests |
|
|
|
- |
- |
|
FCFE Yield |
11.4% |
7.3% |
7.2% |
8.5% |
9.3% |
Total liabilities & equity |
3,583 |
3,351 |
3,179 |
3,113 |
3,023 |
|
EV/EBITDA (x) |
6 9 |
7.3 |
7 5 |
7.4 |
6.6 |
|
|
|
|
|
|
|
Dividend Yield |
5.5% |
5.9% |
6.1% |
6.1% |
6.1% |
Net debt/(cash) |
639 |
932 |
958 |
944 |
952 |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: £ in millions (except per-share data) Fiscal year ends Dec. o/w - out of which
53
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Neutral
Company Data
Price (€) |
14.75 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
17.00 |
Price Target End Date |
31-Dec-19 |
52-week Range (€) |
24.34-14.71 |
Market Cap (€ bn) |
1.86 |
Shares O/S (mn) |
0 |
M6 Group: DCF
Wacc (%) |
9.4% |
Terminal growth rate |
1.0% |
NPV |
|
Present Value of FCF (18-30) |
1,218 |
Present Value of Terminal Value |
790 |
Enterprise Value |
2,008 |
Associates |
20 |
(Net Debt)/Net Cash |
143 |
Equity Value |
2,170 |
Outstanding Shares (bl) |
126 |
Per share |
17 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
M6
M6 (MMTP.PA;MMT FP)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (€) |
1.27 |
1.38 |
1.44 |
1.36 |
Revenue FY (€ mn) |
1,387 |
1,406 |
1,411 |
1,387 |
EBITDA FY (€ mn) |
383 |
403 |
401 |
387 |
EBIT FY (€ mn) |
246 |
270 |
273 |
258 |
EBIT Margin FY |
17.7% |
19.2% |
19.3% |
18.6% |
Bloomberg EPS FY (€) |
1.17 |
1.36 |
- |
1.40 |
Net debt / (cash) FY (€ mn) |
34 |
(143) |
(160) |
(151) |
Net Att. Income FY (€ mn) |
161 |
175 |
182 |
173 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks M6 (Neutral; Price Target: €17.00)
Forecast changes
We have reduced our estimates to account for a more conservative view on French TV & Radio advertising outlook. As a result our 2019 / 20 group revenues decrease by -2% / -3% and our EPS decrease by -5% / -9%.
Investment Thesis
Our underlying view on FTA broadcasters is positive. Given the lack of meaningful upside to our PT, we remain Neutral. We continue to favour other FTA broadcasters such as Pro7 & ITV.
Valuation
Our DCF based Price Target (WACC of 9.4% from 8.6% before, terminal growth of 1%) decreases from €21.0 to €17.0 to reflect our reduced estimates.
Risks to Rating and Price Target
The following risks that could prevent the stock from achieving our target price and rating include: 1) higher / lower-than-expected advertising revenues in FY18 / FY19E; 2) lower / higher-than-expected operating costs in 2018 / 2019E; 3) value enhancing / destructing acquisitions; 4) increase / decrease in audience share.
54
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
M6: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
1,279 |
1,387 |
1,406 |
1,387 |
1,390 |
|
Cash flow from operating activities |
138 |
110 |
158 |
150 |
153 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
140 |
137 |
133 |
128 |
133 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
(21) |
(32) |
(5) |
(5) |
(5) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
385 |
383 |
403 |
387 |
386 |
|
Cash flow from investing activities |
(17) |
(199) |
137 |
(2) |
(2) |
D&A |
(140) |
(137) |
(133) |
(128) |
(133) |
|
o/w Capital expenditure |
(17) |
(198) |
|
0 |
0 |
Adj. EBIT |
244 |
246 |
270 |
258 |
253 |
|
as % of sales |
1.3% |
14.3% |
- |
0.0% |
0.0% |
Net Interest |
1 |
(2) |
(3) |
(2) |
(2) |
|
|
|
|
|
|
|
Adj. PBT |
248 |
248 |
269 |
258 |
252 |
|
Cash flow from financing activities |
(123) |
(32) |
(119) |
(139) |
(155) |
Tax |
(94) |
(88) |
(94) |
(85) |
(80) |
|
o/w Dividends paid |
(106) |
(107) |
(119) |
(139) |
(155) |
Minority Interest |
|
|
|
|
- |
|
o/w Shares issued/(repurchased) |
(15) |
(8) |
0 |
0 |
0 |
Adj. Net Income |
154 |
161 |
175 |
173 |
172 |
|
o/w Net debt issued/(repaid) |
(2) |
83 |
0 |
0 |
0 |
Reported EPS |
1.21 |
1.27 |
1.38 |
1.36 |
1.36 |
|
Net change in cash |
(1) |
(120) |
177 |
8 |
(4) |
Adj. EPS |
1.21 |
1.27 |
1.38 |
1.36 |
1.36 |
|
|
139 |
110 |
158 |
150 |
153 |
DPS |
0.85 |
0.95 |
1.11 |
1.23 |
1.23 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
245.3% |
(20.6%) |
44.0% |
(5.2%) |
2.0% |
||||||
Payout ratio |
70.0% |
74.9% |
80 5% |
90.6% |
90.6% |
|
|
|
|
|
|
|
Shares outstanding |
127 |
127 |
127 |
127 |
127 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A FY17A FY18E FY19E FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
||||
Cash and cash equivalents |
174 |
54 |
231 |
240 |
236 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
|
|
|
|
- |
|
EBITDA margin |
30.1% |
27.6% |
28.6% |
27 9% |
27.8% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
19.1% |
17.7% |
19.2% |
18.6% |
18.2% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
12.1% |
11.6% |
12.4% |
12 5% |
12.4% |
Current assets |
174 |
54 |
231 |
240 |
236 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
1,087 |
1,463 |
1,341 |
1,364 |
1,384 |
|
Net debt/EBITDA |
(44.8%) |
9.0% |
(35.4%) |
(39.0%) |
(38.0%) |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
1.0 |
1.0 |
0.9 |
0.9 |
0.9 |
Total assets |
1,261 |
1,517 |
1,572 |
1,604 |
1,620 |
|
Assets/Equity (x) |
2.0 |
2.2 |
2.2 |
2.2 |
2.1 |
|
|
|
|
|
|
|
Interest cover (x) |
- |
191.5 |
150.7 |
162.5 |
164.5 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
2 |
89 |
89 |
89 |
89 |
|
Tax rate |
37.9% |
35.2% |
35.0% |
33.0% |
31.7% |
Payables |
|
|
|
|
- |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
2 3% |
8 5% |
1.4% |
(1.4%) |
0.2% |
Current liabilities |
2 |
89 |
89 |
89 |
89 |
|
EBITDA y/y Growth |
19.1% |
(0.4%) |
5 2% |
(3.9%) |
(0.2%) |
Long-term debt |
|
|
|
|
- |
|
EPS y/y Growth |
32.7% |
4 5% |
8.8% |
(1.3%) |
(0.3%) |
Other long term liabilities |
643 |
766 |
766 |
766 |
766 |
|
|
|
|
|
|
|
Total liabilities |
645 |
855 |
855 |
855 |
855 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
616 |
662 |
717 |
749 |
765 |
|
P/E (x) |
12.1 |
11.6 |
10.7 |
10.8 |
10.9 |
Minority interests |
|
|
|
|
- |
|
FCFE Yield |
7.4% |
5 9% |
8 3% |
7.9% |
8.1% |
Total liabilities & equity |
1,261 |
1,517 |
1,572 |
1,604 |
1,620 |
|
EV/EBITDA (x) |
4.9 |
5.0 |
4.3 |
4.1 |
3.7 |
|
|
|
|
|
|
|
Dividend Yield |
5.8% |
6.4% |
7 5% |
8.4% |
8.3% |
Net debt/(cash) |
(173) |
34 |
(143) |
(151) |
(147) |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
55
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Underweight
Company Data
Price (€) |
2.60 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
2.00 |
Price Target End Date |
30-Sep-19 |
52-week Range (€) |
3.46-2.43 |
Market Cap (€ bn) |
2.95 |
Shares O/S (mn) |
1,136 |
Mediaset DCF valuation
€ million |
|
WACC |
9.8% |
G |
0.3% |
NPV 2018-30 |
2,321 |
Terminal value |
1,297 |
EV |
3,618 |
Less Net Debt |
-749 |
Less minorities |
-1,238 |
Pay TV value |
200 |
EI Tower |
448 |
Equity |
2,280 |
No Shares |
1,132 |
Equity value / share (€) |
2.0 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
Mediaset
Mediaset (Mediaset SPA) (MS.MI;MS IM)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (€) |
0.10 |
0.15 |
0.22 |
0.21 |
Revenue FY (€ mn) |
3,631 |
3,378 |
3,074 |
3,049 |
Adjusted EBITDA FY (€ |
478 |
461 |
544 |
520 |
mn) |
|
|
|
|
EBITDA Margin FY |
13.2% |
13.7% |
17.7% |
17.1% |
Adjusted EBIT FY (€ mn) |
344 |
373 |
464 |
441 |
Net Profit FY (€ mn) |
115 |
173 |
251 |
237 |
Net debt / (cash) FY (€ mn) |
1,302 |
650 |
594 |
611 |
DPS (Net) FY (€) |
0.00 |
0.08 |
0.13 |
0.13 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks Mediaset (Underweight; Price Target: €2.00)
Investment Thesis
We downgrade Mediaset to UW. Mediaset has outperformed its peers by c25% over the past 3 months despite advertising downgrades in both Italy (driven by the absence of sports events / rights in Q4 2018 / 2019) and Spain, and a significant deterioration in Italian PMI’s in October to the lowest level in 5 years.
Mediaset is the most expensive broadcaster under our coverage, trading on 15x 2019 EV / NOPAT, a 40% premium to the peers, for only slightly stronger growth (c6% vs 4%). We would argue that Mediaset should trade at a discount to the peer group as its earnings are relatively sensitive to the macro environment as a purer play on advertising, with lower margins / higher financial leverage and hence greater operational gearing.
Mediaset ranks poorly in MediaScreen in both the slowdown (31st /32) given small size, high risk, low quality, low growth, and also in the contraction (30th) where the benefit to Mediaset of the increased importance of value at the expense of growth is offset by the increased weighting of risk. Mediaset ranks highly in the “Recovery” (4th) and “Expansion” (8th) but it seems likely that even in the event of a short & shallow slowdown it will be several months before the investment cycle moves back to “Recovery”.
Valuation
We have cut our 2019 earnings by 6% and by 8% in 2020 to reflect weak PMI’s, deficit risks and our reduced GDP growth assumptions (JPMe). Our 2020 EPS is now 7% below the consensus. We cut our PT from €3.1 to €2.0 to reflect forecasts downgrades and also that we have reduced the value of a pay TV settlement with Vivendi / benefit from an ongoing agreement from €500m to €200m to reflect that a legal process is likely to take many years and there seems to be little / no progress on finding a commercial agreement.
Risks to Rating and Price Target
Risks to target price and rating: 1) better advertising trends in Italy and Spain than we have anticipated, 2) stronger growth in the Italian pay-TV subscriber base, 3) better - than-expected profitability of the Italian pay-TV business, 4) any positive update involving Vivendi (shareholding, strategy, legal situation).
56
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Mediaset: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
3,667 |
3,631 |
3,378 |
3,049 |
3,056 |
|
Cash flow from operating activities |
(185) |
(48) |
(5) |
82 |
147 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
|
|
|
|
- |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
44 |
(7) |
(37) |
(24) |
(22) |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
274 |
478 |
461 |
520 |
554 |
|
Cash flow from investing activities |
(18) |
(21) |
(10) |
(10) |
(10) |
D&A |
(134) |
(134) |
(88) |
(80) |
(70) |
|
o/w Capital expenditure |
(15) |
(14) |
(10) |
(10) |
(10) |
Adj. EBIT |
141 |
344 |
373 |
441 |
484 |
|
as % of sales |
0.4% |
0.4% |
0.3% |
0.3% |
0.3% |
Net Interest |
(88) |
(29) |
(21) |
(21) |
(19) |
|
|
|
|
|
|
|
Adj. PBT |
55 |
324 |
383 |
452 |
498 |
|
Cash flow from financing activities |
16 |
(306) |
(465) |
(408) |
(217) |
Tax |
(30) |
(86) |
(110) |
(122) |
(134) |
|
o/w Dividends paid |
(165) |
(173) |
(195) |
(198) |
(167) |
Minority Interest |
(68) |
(123) |
(100) |
(94) |
(93) |
|
o/w Shares issued/(repurchased) |
(87) |
(133) |
0 |
(60) |
(50) |
Adj. Net Income |
(43) |
115 |
173 |
237 |
271 |
|
o/w Net debt issued/(repaid) |
268 |
0 |
(270) |
(150) |
0 |
Reported EPS |
(0.04) |
0.10 |
0.15 |
0 21 |
0 24 |
|
Net change in cash |
(186) |
(374) |
(480) |
(336) |
(80) |
Adj. EPS |
(0.04) |
0.10 |
0.15 |
0.21 |
0.24 |
|
|
62 |
93 |
134 |
207 |
288 |
DPS |
0.00 |
0.00 |
0.08 |
0.13 |
0.14 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
(81.4%) |
49.1% |
44.4% |
54.3% |
39.6% |
||||||
Payout ratio |
0.0% |
0.0% |
50.2% |
60.2% |
60 2% |
|
|
|
|
|
|
|
Shares outstanding |
1,136 |
1,136 |
1,136 |
1,136 |
1,136 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
329 |
90 |
473 |
362 |
438 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
1,688 |
2,049 |
2,269 |
2,303 |
2,335 |
|
EBITDA margin |
7.5% |
13.2% |
13.7% |
17.1% |
18.1% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
3.8% |
9.5% |
11.0% |
14.4% |
15.8% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
(1.2%) |
3.2% |
5.1% |
7.8% |
8.9% |
Current assets |
2,017 |
2,139 |
2,741 |
2,664 |
2,773 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
4,518 |
4,200 |
3,457 |
3,424 |
3,400 |
|
Net debt/EBITDA |
304.0% |
272.6% |
140.9% |
117.4% |
96.4% |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
0 |
0 |
|
Sales/Assets (x) |
0.5 |
0.6 |
0.5 |
0 5 |
0 5 |
Total assets |
6,535 |
6,339 |
6,199 |
6,089 |
6,173 |
|
Assets/Equity (x) |
2.5 |
2 5 |
2.3 |
2 2 |
2 2 |
|
|
|
|
|
|
|
Interest cover (x) |
3.1 |
16.6 |
21.6 |
24 9 |
29.0 |
|
|
|
|
|
|
|
||||||
Short term borrowings |
1,162 |
1,392 |
1,122 |
972 |
972 |
|
Tax rate |
54.2% |
26.4% |
28.8% |
26.9% |
26.8% |
Payables |
2,837 |
2,337 |
2,337 |
2,337 |
2,337 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
4.0% |
(1.0%) |
(7.0%) |
(9.7%) |
0.2% |
Current liabilities |
3,999 |
3,729 |
3,459 |
3,309 |
3,309 |
|
EBITDA y/y Growth |
(25.7%) |
74.2% |
(3.5%) |
12.8% |
6.5% |
Long-term debt |
- |
- |
- |
- |
- |
|
EPS y/y Growth |
(457.3%) |
(369.3%) |
50.1% |
37.1% |
14.7% |
Other long term liabilities |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
Total liabilities |
3,999 |
3,729 |
3,459 |
3,309 |
3,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
2,536 |
2,610 |
2,740 |
2,780 |
2,864 |
|
P/E (x) |
NM |
25.7 |
17.1 |
12 5 |
10 9 |
Minority interests |
|
|
|
|
- |
|
FCFE Yield |
0.0% |
2.2% |
3.8% |
6.3% |
9.1% |
Total liabilities & equity |
6,535 |
6,339 |
6,199 |
6,089 |
6,173 |
|
EV/EBITDA (x) |
13.2 |
7.6 |
7.8 |
7.0 |
6 5 |
|
|
|
|
|
|
|
Dividend Yield |
0.0% |
0.0% |
2.9% |
4.8% |
5.5% |
Net debt/(cash) |
834 |
1,302 |
650 |
611 |
534 |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data) Fiscal year ends Dec. o/w - out of which
57
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Neutral
Company Data
Price (€) |
5.78 |
Date Of Price |
07 Dec 18 |
Price Target (€) |
6.90 |
Price Target End Date |
30-Sep-19 |
52-week Range (€) |
9.81-5.52 |
Market Cap (€ bn) |
2.35 |
Shares O/S (mn) |
406 |
Mediaset Espana DCF valuation
(€m)
Wacc |
9.4% |
G |
0.0% |
Present Value of FCF (18-30) |
1,392 |
Present Value of Terminal Value |
712 |
Enterprise Value |
2,104 |
(Net Debt)/Net Cash |
146 |
Equity Value |
2,249 |
Outstanding Shares (bl) |
327 |
Equity value per Share (€) |
6.9 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
Mediaset España
Mediaset Espana Comunicacion SA (TL5.MC;TL5 SM)
FYE Dec |
2017A |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
Adj. EPS FY (€) |
0.62 |
0.63 |
0.62 |
0.61 |
Adj P/E FY |
9.3 |
9.1 |
9.3 |
9.5 |
Net Profit FY (€ mn) |
205 |
208 |
201 |
196 |
Adjusted EBITDA FY (€ |
262 |
262 |
264 |
256 |
mn) |
|
|
|
|
EBITDA Margin FY |
26.3% |
26.3% |
26.5% |
26.0% |
Bloomberg EPS FY (€) |
0.58 |
0.60 |
- |
0.59 |
Revenue FY (€ mn) |
996 |
994 |
994 |
985 |
Net Debt FY (€ mn) |
(103) |
(113) |
(57) |
(51) |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks
Mediaset España (Neutral; Price Target: €6.90)
Investment Thesis
We downgrade Mediaset Espana from OW to Neutral. Mediaset Espana has outperformed its peers by c10% over the past 3 months with cost savings offsetting slower ad growth, and the shares supported by its cheap valuation. While it continues to trade on <9x 2019 EV/NOPAT, a c15% discount to peers for only slightly slower 3 yr NOPAT growth of c3% vs 4%, it may struggle to outperform our wider universe until leading macro indicators and ad momentum improve.
Q119 should well benefit from the later timing of Easter, although this will put pressure on Q2 which also faces a tough comp without the World Cup. We downgrade our 2019 EPS by c7% to reflect a more cautious macro outlook and slower ad growth – our 2020 EPS is broadly in line with the consensus given our assumption that Mediaset Espana can manage its costs to maintain EBITA in a modest slowdown.
MediaScreen - Mediaset Espana ranks poorly (27/32) in the current “slowdown” phase of the investment cycle given low growth but its ranking improves (18/32) in the “contraction” with support from its cheap valuation and strong balance sheet.
Valuation
Our Sep-19 DCF-based target price decreases from €8.6 to €6.9 (WACC 9.4%, terminal growth of 0%, from 8.6% / 1% respectively) as a result of our forecasts changes (lower TV NAR on more conservative Spanish TV advertising outlook).
Risks to Rating and Price Target
The main risks that we believe could prevent the stock from achieving our target price and rating are: 1) Higher / lower-than-expected increases in TV advertising revenues; 2) higher / lower-than expected audience share in FY18/ FY19; 3) significant deterioration of the European macro environment; and 4) higher / lower-than- expected programming costs.
58
vk.com/id446425943
Daniel Kerven |
Europe Equity Research |
(44-20) 7134-3057 |
10 December 2018 |
daniel kerven@jpmorgan.com |
|
Mediaset España: Summary of Financials
Income Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Cash Flow Statement |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Revenue |
992 |
996 |
994 |
985 |
986 |
|
Cash flow from operating activities |
241 |
227 |
196 |
194 |
193 |
COGS |
- |
- |
- |
- |
- |
|
o/w Depreciation & amortization |
9 |
9 |
8 |
10 |
10 |
Gross profit |
- |
- |
- |
- |
- |
|
o/w Changes in working capital |
28 |
(7) |
0 |
0 |
0 |
SG&A |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
Adj. EBITDA |
241 |
262 |
262 |
256 |
255 |
|
Cash flow from investing activities |
(3) |
7 |
0 |
0 |
0 |
D&A |
(9) |
(9) |
(8) |
(10) |
(10) |
|
o/w Capital expenditure |
(3) |
|
0 |
0 |
0 |
Adj. EBIT |
232 |
253 |
254 |
246 |
244 |
|
as % of sales |
0.3% |
- |
0.0% |
0.0% |
0.0% |
Net Interest |
1 |
2 |
10 |
1 |
1 |
|
|
|
|
|
|
|
Adj. PBT |
234 |
255 |
264 |
247 |
245 |
|
Cash flow from financing activities |
(253) |
(276) |
(185) |
(256) |
(216) |
Tax |
(55) |
(50) |
(56) |
(52) |
(51) |
|
o/w Dividends paid |
(165) |
(173) |
(195) |
(198) |
(167) |
Minority Interest |
0 |
0 |
0 |
0 |
0 |
|
o/w Shares issued/(repurchased) |
(90) |
(105) |
0 |
(60) |
(50) |
Adj. Net Income |
179 |
205 |
208 |
196 |
194 |
|
o/w Net debt issued/(repaid) |
0 |
0 |
0 |
0 |
0 |
Reported EPS |
0.54 |
0.62 |
0.63 |
0.61 |
0.61 |
|
Net change in cash |
(15) |
(42) |
11 |
(62) |
(23) |
Adj. EPS |
0.54 |
0.62 |
0.63 |
0.61 |
0.61 |
|
|
242 |
229 |
204 |
195 |
194 |
DPS |
0.52 |
0.60 |
0.61 |
0.52 |
0.53 |
|
Adj. Free cash flow to firm |
|||||
|
y/y Growth |
12.4% |
(5.5%) |
(11.1%) |
(4.2%) |
(0.7%) |
||||||
Payout ratio |
95.6% |
96.1% |
96 2% |
86.3% |
86.3% |
|
|
|
|
|
|
|
Shares outstanding |
329 |
331 |
327 |
323 |
316 |
|
|
|
|
|
|
|
Balance Sheet |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
|
Ratio Analysis |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Cash and cash equivalents |
193 |
136 |
146 |
84 |
62 |
|
Gross margin |
- |
- |
- |
- |
- |
Accounts receivable |
244 |
272 |
272 |
272 |
272 |
|
EBITDA margin |
24.3% |
26.3% |
26.3% |
26.0% |
25.8% |
Inventories |
|
|
|
|
- |
|
EBIT margin |
23.4% |
25.4% |
25.5% |
25.0% |
24.8% |
Other current assets |
0 |
0 |
0 |
0 |
0 |
|
Net profit margin |
18.0% |
20.6% |
20.9% |
19 9% |
19.7% |
Current assets |
437 |
408 |
419 |
357 |
334 |
|
Organic Revenue growth |
- |
- |
- |
- |
- |
PP&E |
866 |
827 |
826 |
824 |
822 |
|
Net debt/EBITDA |
(64.9%) |
(39.2%) |
(43 3%) |
(20.0%) |
(11.2%) |
LT investments |
|
|
|
|
- |
|
|
|
|
|
|
|
Other non current assets |
0 |
0 |
0 |
(0) |
0 |
|
Sales/Assets (x) |
0.7 |
0.8 |
0.8 |
0.8 |
0.8 |
Total assets |
1,303 |
1,235 |
1,245 |
1,181 |
1,156 |
|
Assets/Equity (x) |
1.3 |
1.3 |
1.4 |
1.4 |
1.4 |
|
|
|
|
|
|
|
Interest cover (x) |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
||||||
Short term borrowings |
- |
- |
- |
- |
- |
|
Tax rate |
23.6% |
19.6% |
21.2% |
21.0% |
20.9% |
Payables |
283 |
302 |
302 |
302 |
302 |
|
|
|
|
|
|
|
Other short term liabilities |
0 |
0 |
0 |
0 |
0 |
|
Revenue y/y Growth |
2.0% |
0.4% |
(0 3%) |
(0.9%) |
0.2% |
Current liabilities |
283 |
302 |
302 |
302 |
302 |
|
EBITDA y/y Growth |
8 2% |
8.8% |
(0 2%) |
(2.1%) |
(0.5%) |
Long-term debt |
37 |
33 |
33 |
33 |
33 |
|
EPS y/y Growth |
8.8% |
14.1% |
2 3% |
(4.7%) |
1.4% |
Other long term liabilities |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
Total liabilities |
319 |
335 |
335 |
335 |
335 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation |
FY16A |
FY17A |
FY18E |
FY19E |
FY20E |
Shareholders' equity |
983 |
900 |
910 |
846 |
821 |
|
P/E (x) |
10.6 |
9.3 |
9.1 |
9.5 |
9.4 |
Minority interests |
|
|
|
|
- |
|
FCFE Yield |
12.8% |
12.0% |
10.9% |
10 5% |
10.6% |
Total liabilities & equity |
1,303 |
1,235 |
1,245 |
1,181 |
1,156 |
|
EV/EBITDA (x) |
7.2 |
6.6 |
6.6 |
6.2 |
5.4 |
|
|
|
|
|
|
|
Dividend Yield |
9.0% |
10.3% |
10.6% |
9.0% |
9.2% |
Net debt/(cash) |
(156) |
(103) |
(113) |
(51) |
(28) |
|
||||||
|
|
|
|
|
|
|
Source: Company reports and J.P. Morgan estimates.
Note: € in millions (except per-share data).Fiscal year ends Dec. o/w - out of which
59
vk.com/id446425943
Daniel Kerven (44-20) 7134-3057
daniel kerven@jpmorgan.com
Neutral
Company Data
Price (p) |
912 |
Date Of Price |
07 Dec 18 |
Price Target (p) |
890 |
Price Target End Date |
30-Sep-19 |
52-week Range (p) |
981-651 |
Market Cap (£ bn) |
7.42 |
Shares O/S (mn) |
813 |
Pearson DCF analysis
WACC |
8.7% |
Terminal growth |
1.2% |
NPV of cash flows to 2030E |
4,158 |
NPV of Terminal Value |
3,212 |
Implied Enterprise Value |
7,369 |
Net debt (end 17E) |
-412 |
Minorities |
-25 |
Implied Equity Value |
6,933 |
Number of shares (m) |
779 |
Fair Value |
890 |
Source: J.P. Morgan estimates.
Europe Equity Research
10 December 2018
Pearson
Pearson (PSON.L;PSON LN)
FYE Dec |
2016A |
2017A |
2018E |
2018E |
2019E |
2019E |
|
|
|
(Prev) |
(Curr) |
(Prev) |
(Curr) |
Adj. EPS FY (p) |
58.84 |
54.08 |
71.11 |
71.44 |
60.10 |
60.74 |
Revenue FY (£ mn) |
4,552 |
4,513 |
4,279 |
4,303 |
4,279 |
4,378 |
EBITDA FY (£ mn) |
785 |
738 |
733 |
736 |
825 |
832 |
EBITDA Margin FY |
17.2% |
16.4% |
17.1% |
17.1% |
19.3% |
19.0% |
Operating profit FY (£ mn) |
635 |
576 |
555 |
558 |
633 |
639 |
Operating margin FY |
13.9% |
12.8% |
13.0% |
13.0% |
14.8% |
14.6% |
DPS (Net) FY (p) |
52.00 |
17.00 |
28.44 |
28.58 |
24.04 |
24.29 |
Bloomberg EPS FY (p) |
55.30 |
52.40 |
- |
59.20 |
- |
56.90 |
Source: Company data, Bloomberg, J.P. Morgan estimates.
Investment Thesis, Valuation and Risks Pearson (Neutral; Price Target: 890p)
Forecast Changes
We have updated our estimates for FX. We maintain our FY18 organic growth forecasts of -4% for US Higher Education, -1% for North America, +2% for Core and -1% for Growth. Our group organic growth remains -0.2% and our EBIT increases from £555m to £558m solely on FX. Our 2018E EPS increases to 71.4p (from 71.1p) as a result. Our 2019E EPS increases by 1% to 60.7p (vs. 60.1p before) as the impact of marginally reduced estimate for North America growth is offset by stronger FX tailwinds.
Investment Thesis
We continue to expect c12-15% EBIT growth in 2019 / 20 & to forecast £105m of incremental cost savings more than offsetting underlying cost inflation. We expect EBIT growth of 12% in 2020 supported by organic growth of 1.0% (vs. 1.6% before as we reduced North America from +1.2% to +0.3%) and a further £100m of savings. We expect PSON to have net cash of c£80m in 2020, prior to the disposal of K12, highlighting the potential for cash returns.
Valuation
Our DCF-based PT remains unchanged at 890p. We continue to assume a mediumterm operating margin of 15% and terminal growth of 1.2% and remain Neutral.
Risks to Rating and Price Target
We see the following upside / downside risks to our estimates, rating and price target: 1) FX movements; 2) Operating margins / cash flow are better / worse than expected due to the economic environment or restructuring charges; 3) Govt education spend is higher / lower than expected; 4) Unemployment rates begin to rise / fall; 5) College enrollments and / or college student spend is higher / lower than expected, or college book returns by retailers are lower / higher than expected; 6) Any M&A is more / less value accretive than expected; 7) Regulatory / political risk; and 8) Competitive pressure (e.g. from print rental, traditional competitors, open education resources etc).
60